Acute plateletpheresis and aprotinin reduces the need for blood transfusion following Ross operation.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

The effect of acute intraoperative plateletpheresis (25% platelet yield) in combination with intraoperative low-dose aprotinin (2 million units) on blood conservation was investigated in 18 young adult patients undergoing elective Ross operation. The results were compared with a group of 19 similar patients without plateletpheresis (control group). The hematological and coagulation parameters at admission and discharge were statistically similar in both groups. The total blood product transfusion requirements were significantly reduced in the plateletpheresis group compared with the control group (3.2 units and 5.1 units, respectively, P=0.036). The total blood donor exposure was also reduced significantly in the plateletpheresis group compared with the control group (3.2 and 6.9 donors/patient, respectively, P<0.001). The direct costs for the hospital for the plateletpheresis procedure, including costs for all blood products, were similar to those for blood products alone in the control group. In summary, acute plateletpheresis in combination with low-dose aprotinin significantly reduces the blood product transfusions and blood donor exposures following the Ross operation; the treatment is cost-effective.

Detaljer

Författare
Externa organisationer
  • Skåne University Hospital
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Klinisk medicin
Originalspråkengelska
Sidor (från-till)618-622
TidskriftInteractive Cardiovascular and Thoracic Surgery
Volym6
Utgåva nummer5
Tidigt onlinedatum2007 jul 25
StatusPublished - 2007
PublikationskategoriForskning
Peer review utfördJa
Externt publiceradJa

Relaterad forskningsoutput

Alrashidi, F., 2010, Heart and Lung division, Faculty of Medicine. 150 s.

Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

Visa alla (1)